Related references
Note: Only part of the references are listed.Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
Sanjay K. Murthy et al.
GUT (2020)
Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study
Anne K. Ortqvist et al.
GUT (2019)
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease
Byron P. Vaughn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease
Margaret Delday et al.
INFLAMMATORY BOWEL DISEASES (2019)
You are what you eat: diet, health and the gut microbiota
Niv Zmora et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases
Louis J. Cohen et al.
GASTROENTEROLOGY (2019)
Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties
Michele Biagioli et al.
NUTRIENTS (2019)
Emerging roles of bile acids in mucosal immunity and inflammation
Mei Lan Chen et al.
MUCOSAL IMMUNOLOGY (2019)
The Integrative Human Microbiome Project
Lita M. Proctor et al.
NATURE (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
Infection-Induced Intestinal Dysbiosis Is Mediated by Macrophage Activation and Nitrate Production
Shuai Wang et al.
MBIO (2019)
Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis
Levi M. Teigen et al.
NUTRIENTS (2019)
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective
Sara Onali et al.
CELLS (2019)
Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease
Paolo Giuffrida et al.
CELLS (2019)
The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells
Sara Omenetti et al.
IMMUNITY (2019)
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Yi Rang Na et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages
Marco Orecchioni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Reactive nitrogen species in host-bacterial interactions
Ferric C. Fang et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sudarshan Paramsothy et al.
GASTROENTEROLOGY (2019)
Role of the microbiome in human development
Maria Gloria Dominguez-Bello et al.
GUT (2019)
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies
Paulo Jose Basso et al.
FRONTIERS IN PHARMACOLOGY (2019)
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens
Hong-Yu Cheng et al.
FRONTIERS IN IMMUNOLOGY (2019)
Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model
Faith D. Ihekweazu et al.
GUT MICROBES (2019)
Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
Michael Kriss et al.
CURRENT OPINION IN MICROBIOLOGY (2018)
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis
Makoto Naganuma et al.
GASTROENTEROLOGY (2018)
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease
Taekil Eom et al.
JOURNAL OF MICROBIOLOGY (2018)
Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice
Baoren Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease
D. Bernardo et al.
MUCOSAL IMMUNOLOGY (2018)
Current understanding of the human microbiome
Jack A. Gilbert et al.
NATURE MEDICINE (2018)
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies
Bani Ahluwalia et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease
Katharine G. Harris et al.
CLINICAL SCIENCE (2018)
Precision editing of the gut microbiota ameliorates colitis
Wenhan Zhu et al.
NATURE (2018)
Environment dominates over host genetics in shaping human gut microbiota
Daphna Rothschild et al.
NATURE (2018)
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo et al.
FRONTIERS IN MICROBIOLOGY (2018)
Indole-3-Pyruvic Acid, an Aryl Hydrocarbon Receptor Activator, Suppresses Experimental Colitis in Mice
Reiji Aoki et al.
JOURNAL OF IMMUNOLOGY (2018)
Molecular and functional heterogeneity of IL-10-producing CD4+ T cells
Leonie Brockmann et al.
NATURE COMMUNICATIONS (2018)
Causal effects of the microbiota on immune-mediated diseases
June L. Round et al.
SCIENCE IMMUNOLOGY (2018)
Gut microbiota in the pathogenesis of inflammatory bowel disease
Atsushi Nishida et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2018)
Formation of propionate and butyrate by the human colonic microbiota
Petra Louis et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
Effects of prebiotics on immune system and cytokine expression
Parisa Shokryazdan et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2017)
The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease
Adeline Sivignon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
R. Balfour Sartor et al.
GASTROENTEROLOGY (2017)
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases
Clara Abraham et al.
GASTROENTEROLOGY (2017)
The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis
Michele Biagioli et al.
JOURNAL OF IMMUNOLOGY (2017)
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
Sudarshan Paramsothy et al.
LANCET (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues
D. Sichien et al.
MUCOSAL IMMUNOLOGY (2017)
Barrier-tissue macrophages: functional adaptation to environmental challenges
Allan Mcl Mowat et al.
NATURE MEDICINE (2017)
Gut microbiota and IBD: causation or correlation?
Josephine Ni et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation
Koji Atarashi et al.
SCIENCE (2017)
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Mariana X. Byndloss et al.
SCIENCE (2017)
IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation
Monica Viladomiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine
C. C. Bain et al.
NATURE COMMUNICATIONS (2017)
rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway
Lifu Wang et al.
THERANOSTICS (2017)
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases
Suguru Shigemori et al.
FRONTIERS IN IMMUNOLOGY (2017)
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
Paul W. O'Toole et al.
NATURE MICROBIOLOGY (2017)
Host-microbial Cross-talk in Inflammatory Bowel Disease
Hiroko Nagao-Kitamoto et al.
IMMUNE NETWORK (2017)
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice
Lien Van den Bossche et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases
R. B. Sartor
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
Monika Schaubeck et al.
GUT (2016)
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease
E. Quevrain et al.
GUT (2016)
Foxp3+ T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation
B-H Yang et al.
MUCOSAL IMMUNOLOGY (2016)
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
Kenichiro Takahashi et al.
DIGESTION (2016)
Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease
Sen Yagi et al.
INFLAMMATORY BOWEL DISEASES (2016)
Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces
Chigusa Nakahashi-Oda et al.
NATURE IMMUNOLOGY (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas et al.
NATURE MEDICINE (2016)
Role of antibiotics for treatment of inflammatory bowel disease
Orna Nitzan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Functional Characterization of Inflammatory Bowel Disease-Associate Gut Dysbiosis in Gnotobiotic Mice
Hiroko Nagao-Kitamoto et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)
Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
Koji Atarashi et al.
CELL (2015)
Antibiotics, Pediatric Dysbiosis, and Disease
Pajau Vangay et al.
CELL HOST & MICROBE (2015)
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease
James D. Lewis et al.
CELL HOST & MICROBE (2015)
Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases
Jonathan J. Hansen
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
The role of IL-10 in microbiome-associated immune modulation and disease tolerance
Benoit Levast et al.
CYTOKINE (2015)
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
Aze Wilson et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Food, Immunity, and the Microbiome
Herbert Tilg et al.
GASTROENTEROLOGY (2015)
Conjugated Bile Acid-Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression
Masayuki Nagahashi et al.
HEPATOLOGY (2015)
IL-10-independent regulatory B-cell subsets and mechanisms of action
Avijit Ray et al.
INTERNATIONAL IMMUNOLOGY (2015)
A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease
Takanori Kanai et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota
M. Sun et al.
MUCOSAL IMMUNOLOGY (2015)
Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells
Esen Sefik et al.
SCIENCE (2015)
Bile acid nuclear receptor FXR and digestive system diseases
Lili Ding et al.
ACTA PHARMACEUTICA SINICA B (2015)
Commensal microbiota regulates T cell fate decision in the gut
Yukihiro Furusawa et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Resident Bacteria-Stimulated Interleukin-10-Secreting B Cells Ameliorate T-Cell-Mediated Colitis by Inducing T-Regulatory-1 Cells That Require Interleukin-27 Signaling
Yoshiyuki Mishima et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid et al.
CELL (2014)
The Treatment-Naive Microbiome in New-Onset Crohn's Disease
Dirk Gevers et al.
CELL HOST & MICROBE (2014)
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Miranda L. Hanson et al.
GASTROENTEROLOGY (2014)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
Dror S. Shouval et al.
IMMUNITY (2014)
Induction of Bacterial Antigen-Specific Colitis by a Simplified Human Microbiota Consortium in Gnotobiotic Interleukin-10-/- Mice
Chang Soo Eun et al.
INFECTION AND IMMUNITY (2014)
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report
Dan Turner et al.
JOURNAL OF CROHNS & COLITIS (2014)
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
David Bikard et al.
NATURE BIOTECHNOLOGY (2014)
Complex host genetics influence the microbiome in inflammatory bowel disease
Dan Knights et al.
GENOME MEDICINE (2014)
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
Zain Kassam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
Teresa Zelante et al.
IMMUNITY (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Koji Atarashi et al.
NATURE (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
Why interleukin-10 supplementation does not work in Crohn's disease patients
Gareth J. Marlow et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Regulation of Intestinal Homeostasis by Innate Immune Cells
Hisako Kayama et al.
Immune Network (2013)
The Colitis-Associated Transcriptional Profile of Commensal Bacteroides thetaiotaomicron Enhances Adaptive Immune Responses to a Bacterial Antigen
Jonathan J. Hansen et al.
PLOS ONE (2012)
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota
June L. Round et al.
SCIENCE (2011)
Intestinal CD103+ dendritic cells: master regulators of tolerance?
Charlotte L. Scott et al.
TRENDS IN IMMUNOLOGY (2011)
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease
Sergio Rutella et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Newly Developed Antibiotic Combination Therapy for Ulcerative Colitis: A Double-Blind Placebo-Controlled Multicenter Trial
Toshifumi Ohkusa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice
Yoshiyuki Mishima et al.
IMMUNOLOGY (2010)
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
K. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2010)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease
D. K. Amre et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Erik-Oliver Glocker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells
Matthias Lochner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility
Andre Franke et al.
NATURE GENETICS (2008)
Therapeutic correction of bacterial dysbiosis discovered by molecular techniques
R. Balfour Sartor
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria
SC Kim et al.
GASTROENTEROLOGY (2005)
T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation
A Roers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics
RB Sartor
GASTROENTEROLOGY (2004)
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
A Mizoguchi et al.
IMMUNITY (2002)
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
JF Colombel et al.
GUT (2001)
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
S Schreiber et al.
GASTROENTEROLOGY (2000)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Share Paper
